Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Sensors (Basel) ; 22(3)2022 Jan 18.
Artículo en Inglés | MEDLINE | ID: mdl-35161448

RESUMEN

Behavior modeling has multiple applications in the intelligent environment domain. It has been used in different tasks, such as the stratification of different pathologies, prediction of the user actions and activities, or modeling the energy usage. Specifically, behavior prediction can be used to forecast the future evolution of the users and to identify those behaviors that deviate from the expected conduct. In this paper, we propose the use of embeddings to represent the user actions, and study and compare several behavior prediction approaches. We test multiple model (LSTM, CNNs, GCNs, and transformers) architectures to ascertain the best approach to using embeddings for behavior modeling and also evaluate multiple embedding retrofitting approaches. To do so, we use the Kasteren dataset for intelligent environments, which is one of the most widely used datasets in the areas of activity recognition and behavior modeling.


Asunto(s)
Redes Neurales de la Computación , Humanos
2.
J Biomed Inform ; 64: 108-115, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27693564

RESUMEN

The increase of life expectancy in modern society has caused an increase in elderly population. Elderly people want to live independently in their home environment for as long as possible. However, as we age, our physical skills tend to worsen and our social circle tends to become smaller, something that often leads to a considerable decrease of both our physical and social activities. In this paper, we present an AAL framework developed within the SONOPA project, whose objective is to promote active ageing by combining a social network with information inferred using in-home sensors.


Asunto(s)
Envejecimiento , Apoyo Social , Actividades Cotidianas , Humanos , Monitoreo Ambulatorio , Telemedicina
3.
Front Oncol ; 13: 1048593, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36798825

RESUMEN

Patients surviving head and neck cancer (HNC) suffer from high physical, psychological, and socioeconomic burdens. Achieving cancer-free survival with an optimal quality of life (QoL) is the primary goal for HNC patient management. So, maintaining lifelong surveillance is critical. An ambitious goal would be to carry this out through the advanced analysis of environmental, emotional, and behavioral data unobtrusively collected from mobile devices. The aim of this clinical trial is to reduce, with non-invasive tools (i.e., patients' mobile devices), the proportion of HNC survivors (i.e., having completed their curative treatment from 3 months to 10 years) experiencing a clinically relevant reduction in QoL during follow-up. The Big Data for Quality of Life (BD4QoL) study is an international, multicenter, randomized (2:1), open-label trial. The primary endpoint is a clinically relevant global health-related EORTC QLQ-C30 QoL deterioration (decrease ≥10 points) at any point during 24 months post-treatment follow-up. The target sample size is 420 patients. Patients will be randomized to be followed up using the BD4QoL platform or per standard clinical practice. The BD4QoL platform includes a set of services to allow patients monitoring and empowerment through two main tools: a mobile application installed on participants' smartphones, that includes a chatbot for e-coaching, and the Point of Care dashboard, to let the investigators manage patients data. In both arms, participants will be asked to complete QoL questionnaires at study entry and once every 6 months, and will undergo post-treatment follow up as per clinical practice. Patients randomized to the intervention arm (n=280) will receive access to the BD4QoL platform, those in the control arm (n=140) will not. Eligibility criteria include completing curative treatments for non-metastatic HNC and the use of an Android-based smartphone. Patients undergoing active treatments or with synchronous cancers are excluded. Clinical Trial Registration: ClinicalTrials.gov, identifier (NCT05315570).

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA